dr. eng discusses the beacon crc study in braf-mutated crc
Published 5 years ago • 270 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:09
dr. kopetz on updated data from beacon crc study in braf v600e–mutant crc
-
1:11
dr. kopetz on the rationale for the beacon crc study in braf v600e-mutant mcrc
-
1:07
dr. eng on ongoing studies for braf-mutant crc
-
0:54
dr. kopetz on safety data from beacon crc trial in braf v600e-mutant mcrc
-
1:54
dr. kopetz on the rationale and primary endpoints of the beacon crc study in mcrc
-
3:42
evidence in braf-mutant crc tumors
-
1:08
ongoing clinical trials in braf-mutant crc
-
1:20
jeffrey a. meyerhardt, md, considers the beacon study in braf mutated metastatic colorectal cancer
-
32:42
bryan kestenbaum, md - volume: the other uremic toxin
-
46:42
adrenal fatigue: the hidden crisis in malaysia | dr roland victor ft dr jon
-
1:17
treatment approaches for braf v600e mutant metastatic colorectal cancer
-
7:02
triplet regimens in braf-mutant metastatic crc
-
0:58
stefan kasper, md, provides updates on the beacon trial in braf-mutant crc
-
1:44
dr. kopetz discusses the treatment of braf-mutant crc
-
4:19
targeting braf in metastatic crc
-
8:16
beacon crc: first-line bevacizumab in colorectal cancer treatment
-
0:50
dr. bendell discusses two studies in braf-mutated crc
-
1:00
dr. kopetz discusses triplet therapy for braf-mutant crc
-
1:05
dr. nelson on qol data from the beacon crc trial in mcrc
-
2:21
editorial - braf mutation in colorectal cancer: an enigmatic target
-
1:34
dr. kopetz on the biology of right- versus left-sided crc
-
6:01
beacon trial: triplet therapy in braf v600e–mutated mcrc